ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $371,000 | -16.3% | 3,884 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $443,000 | -16.6% | 3,884 | +1.3% | 0.01% | -16.7% |
Q4 2020 | $531,000 | +65.4% | 3,834 | -1.7% | 0.01% | +50.0% |
Q3 2020 | $321,000 | -74.5% | 3,900 | -75.8% | 0.00% | -77.8% |
Q2 2020 | $1,260,000 | +76.0% | 16,100 | 0.0% | 0.02% | +63.6% |
Q1 2020 | $716,000 | +3.0% | 16,100 | 0.0% | 0.01% | +57.1% |
Q4 2019 | $695,000 | +0.9% | 16,100 | 0.0% | 0.01% | -12.5% |
Q3 2019 | $689,000 | -32.6% | 16,100 | 0.0% | 0.01% | -27.3% |
Q2 2019 | $1,023,000 | +1523.8% | 16,100 | +1688.9% | 0.01% | +1000.0% |
Q1 2019 | $63,000 | +57.5% | 900 | -0.8% | 0.00% | 0.0% |
Q4 2018 | $40,000 | -42.0% | 907 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $69,000 | -1.4% | 907 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $70,000 | +52.2% | 907 | 0.0% | 0.00% | – |
Q1 2018 | $46,000 | +9.5% | 907 | 0.0% | 0.00% | – |
Q4 2017 | $42,000 | -12.5% | 907 | 0.0% | 0.00% | – |
Q3 2017 | $48,000 | -14.3% | 907 | 0.0% | 0.00% | – |
Q2 2017 | $56,000 | -8.2% | 907 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $61,000 | +6000.0% | 907 | +12857.1% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 7 | +40.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 5 | +66.7% | 0.00% | – |
Q4 2015 | $1,000 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |